- Report
- February 2026
- 281 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 170 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 367 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 194 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 277 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 480 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 470 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 273 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 374 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 369 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 484 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 116 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 393 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 287 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 278 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 179 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 483 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 204 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 282 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 371 Pages
Global
From €5103EUR$5,850USD£4,447GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more